Biocon gets nod to transfer biosimilars business

09 Dec 2017 Evaluate

Biocon has received its shareholders’ approval to the resolution for transfer of biosimilars business by way of a slump sale to group entity Biocon Biologics India. The resolution for transfer of Biosimilars business of the company by way of a slump sale as ‘Going Concern’ to Biocon Biologics India has been passed by the members of the company with requisite majority. The special resolution was passed with 99.99 per cent of votes polled through postal ballot.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

307.00 15.30 (5.25%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.